Ali Behbahani
Director at CRISPR Therapeutics AG (CRSP); Director at SpyGlass Pharma, Inc. (SGP)
Purchase track record
Not enough history. Based on 1 purchase with a full 90 days of price history.
—
Avg. 90-day return-12.4%
vs. S&P 500-19.3%
Beat the market0%
Paper profit on buys+$8.4M
Total bought / sold$15.0M / $781K
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Sep 21SEC | CRSPCRISPR Therapeutics AG | Sell | 13,67916,637 held (−45%) | $57.09 | $781K | -6.5% |
| Feb 11SEC | SGPSpyGlass Pharma, Inc. | Buy | 937,5006,035,038 held (+18%) | $16.00 | $15.0M | +55.8% |
- Sell
Director Ali Behbahani sold $781K of CRSP at $57.09 — cuts the stake by 45%.
- Buy
Director Ali Behbahani bought $15.0M of SGP at $16.00 — first open-market purchase in our records.